Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Advanced Ovarian Cancer
NCT00002928Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jan 1997
- Primary completion
- Aug 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in ovarian cancer, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Activity of Paclitaxel. Started Jan 1997; status: completed.
02
Drugs
paclitaxel
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00002928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002928.